Afuco™ Anti-Human BTNL9 ADCC Therapeutic Antibody, ADCC Enhanced

Anti-BTNL9 ADCC Enhanced Antibody is an ADCC enhanced antibody produced by our Afuco™ platform. The anti-BTNL9 antibody increases the inhibition of proliferation of T cells by the soluble multimeric BTNL9 protein, used for treating autoimmune or inflammatory disease.
Supplier Creative Biolabs
Product # AFC-074CL
Pricing Inquiry
Host Human
Target BTNL9
Species Reactivity Human
Type ADCC enhanced antibody
Storage Store at 4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Feedback